drugset / Trial / NCT00000102
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
Parallel-groupDouble-blindTreatment
Summary
This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nifedipine | Other / unclassified | — | — |